Patents Assigned to Med-Mark Pharma GmbH
  • Edelfosin for the treatment of brain tumors
    Patent number: 6514519
    Abstract: Octadecyl-2-methyl-sn-glycero-3-phosphocholine (edelfosine) is suitable for the treatment of brain tumors and can therefore be used to produce a drug for the treatment of brain tumors which can also be administered orally.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: February 4, 2003
    Assignee: Med-Mark Pharma GmbH
    Inventor: Apollonia Nagler